Price of insulin skyrockets, leaving diabetics with no recourse
DENVER -- Drug spending in the U.S. increased by 20 percent from 2013 to 2015, according to a study published by the American Medical Association. Last year, Americans saw egregious examples of price increases, including the cost of an Epipen. Now, millions of diabetics, members of Congress and the Diabetes Association are calling for hearings to investigate why the cost of insulin continues to rise.